BioNTech SE ADR buy Amped
Start price
29.11.21
/
0%
€316.90
Target price
29.11.22
-
Performance (%)
-49.87%
End price
30.11.22
€158.85
Summary
This prediction ended on 30.11.22 with a price of €158.85. Massive losses of -49.87% were the result for the BUY prediction by Amped. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% |
According to Amped what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Top Rating
High Investments for future growth
Valuable balance sheet
Small challenges to pay loans and raise capital
Fair valuation
Very capable Management
Very good company culture
Leading role in innovation
Strong uniques
Differentiated customer and product portfolio
Growths much faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Sustainability is little important
Comments by Amped for this prediction
In the thread Biontech SE diskutieren
Buy BioNTech SE ADR
In the thread Trading Biontech SE
Die von Amped gewählte maximale Laufzeit wurde überschritten